COMMUNIQUÉS West-GlobeNewswire

Rentschler Biopharma Announces Executive Board Changes and Next Phase of Corporate Strategy
20/01/2026
Company implements next growth stage following successful strategic and operational development Uwe Buecheler, PhD, Vice Chairman of the Supervisory Board, appointed interim CEO LAUPHEIM, Germany and MILFORD, Mass., Jan [...]
MAIA Biotechnology Advances Ateganosine Cancer Treatment Program, Outlines Targeted 2026 Clinical Milestones and Growth Momentum
20/01/2026
High probability of technical success in pivotal Phase 3 trial based on unmatched efficacy data for third-line non-small cell lung cancer (NSCLC) treatment FDA’s Fast Track designation for ateganosine in NSCLC advances [...]
Comfort Keepers Ireland Highlights Urgent Need for Scaling Safe, Regulated Home Support
20/01/2026
Report Emphasises the Importance of Home Support in Alleviating Hospital Pressures and Supporting Aging Population Dublin, Ireland, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Comfort Keepers Ireland , a leading homecare provider [...]
Adaptin Bio Advances Novel Brain Cancer Treatment Candidate Towards Phase 1 Glioblastoma Clinical Trial
20/01/2026
The Preston Robert Tisch Brain Tumor Center grants first IRB approval for APTN-101’s Phase I clinical trial, enabling patient recruitment to begin APTN-101, the Company’s Brain Bispecific T cell Engager (BRiTE), yields [...]
First-of-its-kind Trojan Horse Cancer Treatment Approved for Clinical Trials
20/01/2026
Peptinovo Biopharma’s Targeted Cancer Drug Platform Moves to Human Trials in Australia ANN ARBOR, Mich., Jan. 20, 2026 (GLOBE NEWSWIRE) -- Peptinovo Biopharma, an Ann Arbor–based biotechnology company pioneering [...]
New National Report: Nurse-Led Coordination Strengthens Patient Access, Reduces Delays and Improves Throughput Across U.S. Health Systems
20/01/2026
Survey finds nurse-first models help avoid three-quarters of unnecessary ED visits, are rated highly effective for reducing readmissions, and enhance patient outcomes through streamlined coordination Cincinnati, Jan. 20 [...]
Capricor Therapeutics Provides Regulatory Update on Deramiocel BLA Following FDA Review of HOPE-3 Topline Data
20/01/2026
FDA has requested the HOPE-3 clinical study report (CSR) as part of the BLA review process Company expects to submit updates to the BLA in February 2026 to support continued FDA review SAN DIEGO, Jan. 20, 2026 (GLOBE [...]
TOMI Environmental Solutions Secures UK CES contract integrating SteraMist iHP into Total Clean Air's Modular Cleanroom Platform
20/01/2026
FREDERICK, Md., Jan. 20, 2026 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. ® (“TOMI”) (NASDAQ: TOMZ), a global leader in disinfection and decontamination solutions, today announced the sale of a Custom [...]
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
20/01/2026
MIAMI, Jan. 20, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company”), developer of the CGuard™ Prime carotid stent system for the prevention of stroke, today announced that the [...]
BioAge Announces Indication Expansion for Oral NLRP3 Inhibitor BGE-102, with Plans to Initiate Phase 1b/2a Proof-of-Concept Clinical Trial in Patients with Diabetic Macular Edema in Mid-2026
20/01/2026
BGE-102 has the potential for therapeutic retinal exposure with oral delivery, reducing treatment burden in ocular indications currently treated with intravitreal therapies Growing preclinical and clinical evidence [...]
New Imprivata Survey Finds 85% of Healthcare IT Leaders Think Passwordless Authentication is Vital, but Adoption Lags Significantly
20/01/2026
Just 7% of organizations have fully adopted passwordless authentication, citing technical integration challenges and clinical training concerns WALTHAM, Mass., Jan. 20, 2026 (GLOBE NEWSWIRE) -- Imprivata , a leading [...]
Interpace Biosciences Announces Preliminary 2025 Revenue, 2026 Revenue Guidance and Simplification of Capital Structure
20/01/2026
Preliminary 2025 thyroid testing revenue grew 21% over prior year Initial 2026 guidance of 16% growth in thyroid testing revenue All preferred stock converted to common stock Debt-free balance sheet and positive Net [...]
SPARK NS and Haukeland University Hospital Announce Clinical Trial of D-Serine for Modifying Parkinson’s Disease Progression
20/01/2026
Previous research indicates that D-Serine is safe, tolerable, and holds promise as a potential neuroprotective treatment for Parkinson’s MENLO PARK, Calif. and BERGEN, Norway, Jan. 20, 2026 (GLOBE NEWSWIRE) -- SPARK NS [...]
Polarean Expands Xenon MRI Platform into Cardiopulmonary Drug Development with Multi-Center PH-ILD Study
20/01/2026
Innovative Trial Design to Directly Measure Microvascular Functional Effects of Inhaled Therapy at the Capillary level of Pulmonary Hypertension Patients with Interstitial Lung Disease (PH-ILD) DURHAM, NC and LONDON, [...]
Propanc Biopharma Files New Provisional Patent Application for Methods of Producing Trypsinogen & Chymotrypsinogen with IP Australia
20/01/2026
A World-First, Fully Synthetic Recombinant Version of PRP MELBOURNE, , Jan. 20, 2026 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company focused on [...]
BrightInsight Strengthens Executive Leadership Team with Three Key Hires to Accelerate Global Growth and Innovation
20/01/2026
SAN JOSE, Calif., Jan. 20, 2026 (GLOBE NEWSWIRE) -- BrightInsight, Inc ., the leading global platform for biopharma digital health solutions, today announced the appointment of three industry veterans to its Executive [...]
FibroBiologics to Present at the DealFlow Discovery Conference
20/01/2026
HOUSTON, Jan. 20, 2026 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of [...]
InStride Health and The Wharton School Showcase Successful AI Scribe Adoption for Improved Clinician Efficiency and Experience
20/01/2026
Case study highlights how collaboration from clinical and technical teams drive effective, responsible, and scalable AI adoption in behavioral health BOSTON and PHILADELPHIA, Jan. 20, 2026 (GLOBE NEWSWIRE) -- InStride [...]
BrightInsight Announces Multi-Million Dollar Strategic Investment to Advance its AI-Enabled Medication Persistence and Adherence Solutions
20/01/2026
SAN JOSE, Calif., Jan. 20, 2026 (GLOBE NEWSWIRE) -- BrightInsight , a leader in digital health solutions, today announced a new investment round of $13 million from existing and new investors including Eclipse, General [...]

Pages